Skip to content

Electrical Stimulation in Patients With Prolonged Mechanical Ventilation

Effects of Muscular Electrical Stimulation on Skeletal and Lung Mechanics in Patients With Prolonged Mechanical Ventilation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02227810
Enrollment
53
Registered
2014-08-28
Start date
2012-08-31
Completion date
2014-07-31
Last updated
2017-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Failure

Keywords

Prolong mechanical ventilator,, Electrical stimulation,, Activities of daily life,, Hospitalization outcomes.

Brief summary

Muscle atrophy and diaphragm dysfunction are common complication in patients with prolong mechanical ventilator (PMV) and is associated with increased rate of weaning failure and days of hospitalization. Electrical stimulation (ES) has been shown to be beneficial in patients with severe chronic heart failure and chronic obstructive pulmonary disease. The purpose of this study is to examine the effects of ES on skeletal muscle function, pulmonary mechanics and hospitalization outcomes in patients with PMV.

Detailed description

BACKGROUND AND PURPOSE: Muscle atrophy and diaphragm dysfunction are common complication in patients with prolong mechanical ventilator (PMV) and is associated with increased rate of weaning failure and days of hospitalization. Electrical stimulation (ES) has been shown to be beneficial in patients with severe chronic heart failure and chronic obstructive pulmonary disease. The purpose of this study is to examine the effects of ES on skeletal muscle function, pulmonary mechanics and hospitalization outcomes in patients with PMV. METHODS: Patients who have been on mechanical ventilator for more than 21 days will be recruited from respiratory care center (RCC). All subjects will be randomly assigned into three groups: ES in abdominal muscles (ES-Abd, n=30),ES in brachial biceps (ES-bicep, n=30) and sham group(Sham). Subjects in both groups will receive ES in muscles for 30 min/session, 2 sessions/day for 10 days with the same setting except area of ES. The muscle function will be assessed by skin-fold thickness and muscle strength. The pulmonary function will be assessed by: lung compliance, airway resistance, tidal volume, minute volume and maximal inspiratory pressure. The hospitalization outcome will be followed up until patients are discharged from RCC. The outcomes variables include: weaning rate and duration, mortality, days of ventilator, and length of RCC stay.

Interventions

OTHERelectrical stimulation (high frequency)

Participants will receive muscular electrical stimulation (75Hz) on quadriceps muscle for 20 min/session, twice daily for 10 days

OTHERelectrical stimulation (low frequency)

Participants will receive muscular electrical stimulation (35Hz) on quadriceps muscle for 20 min/session, twice daily for 10 days.

OTHERsham group

Participants will receive similar electrical stimulation (ES) procedure as those in intervention group but with ES machine power off.

Sponsors

Chang Gung Memorial Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
20 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* age\>20 years old * mechanical ventilation for more than 6 h/ day for more than 21 days -- medical stability (arterial blood gas value hydrogen power(pH): 7.35-7.45, atrial oxygen pressure(PaO2): 60 mmHg at 40% fraction of inspired oxygen inspired oxygen fraction (FiO2), absence of signs and symptoms of infection, and hemodynamic stability);

Exclusion criteria

* signs of acute infection (BT\>38.5℃,WBC\>12000 or \<3000 per unit * neuromuscular disease at acute stage * diagnosis of cancer at end-stage * pregnancy * BMI\>35kg/m2

Design outcomes

Primary

MeasureTime frameDescription
Pulmonary Functionend of interventionThe pulmonary function as assessed by the measurement of tidal volume.
Level of Activity of Daily Lifeend of interventionThe level of activity of daily life was measured by Functional Independence Measure (FIM) score. Possible scores range from 18 (total assist) to 126 (complete independence).
Muscle Strengthend of interventionThe muscle strength of quadriceps were assessed by Medical Research Council (MRC) scoring system. The MRC score ranges from a 0 points (zero strength) to 5 points (good). The higher points indicated the better muscle strength.

Secondary

MeasureTime frameDescription
Hospitalization Outcomesthe day participants were discharged from RCCThe total days that participants stay in the respiratory care center (RCC).

Countries

Taiwan

Participant flow

Recruitment details

Recruitment period: 2012/08/01--2014/07/31 Location: respiratory care center

Participants by arm

ArmCount
Electrical Stimulation
Participants will receive muscular electrical stimulation on quadriceps muscle for 20 min/session, twice daily for 10 days electrical stimulation (high frequency): Participants will receive muscular electrical stimulation (75Hz) on quadriceps muscle for 20 min/session, twice daily for 10 days electrical stimulation (low frequency): Participants will receive muscular electrical stimulation (35Hz) on quadriceps muscle for 20 min/session, twice daily for 10 days.
34
Sham Group
Participants will receive similar electrical stimulation (ES) procedure as those in intervention group but with ES machine power off. sham group: Participants will receive similar electrical stimulation (ES) procedure as those in intervention group but with ES machine power off.
19
Total53

Baseline characteristics

CharacteristicSham GroupTotalElectrical Stimulation
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
13 Participants42 Participants29 Participants
Age, Categorical
Between 18 and 65 years
6 Participants11 Participants5 Participants
Age, Continuous71.9 years
STANDARD_DEVIATION 17.8
74.5 years
STANDARD_DEVIATION 15.4
75.2 years
STANDARD_DEVIATION 15.4
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
19 Participants53 Participants34 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
0 Participants0 Participants0 Participants
Region of Enrollment
Taiwan
19 participants53 participants34 participants
Sex: Female, Male
Female
9 Participants23 Participants14 Participants
Sex: Female, Male
Male
10 Participants30 Participants20 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 190 / 34
other
Total, other adverse events
0 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 0

Outcome results

Primary

Level of Activity of Daily Life

The level of activity of daily life was measured by Functional Independence Measure (FIM) score. Possible scores range from 18 (total assist) to 126 (complete independence).

Time frame: end of intervention

ArmMeasureValue (MEAN)Dispersion
Sham GroupLevel of Activity of Daily Life25.2 units on a scaleStandard Deviation 14.5
Electrical StimulationLevel of Activity of Daily Life32.0 units on a scaleStandard Deviation 21.4
p-value: 0.652t-test, 2 sided
p-value: 0.123t-test, 2 sided
Primary

Muscle Strength

The muscle strength of quadriceps were assessed by Medical Research Council (MRC) scoring system. The MRC score ranges from a 0 points (zero strength) to 5 points (good). The higher points indicated the better muscle strength.

Time frame: end of intervention

ArmMeasureValue (MEAN)Dispersion
Sham GroupMuscle Strength1.7 units on a scaleStandard Deviation 1.1
Electrical StimulationMuscle Strength2.7 units on a scaleStandard Deviation 1.6
p-value: 0.051t-test, 2 sided
p-value: <0.05t-test, 2 sided
Primary

Pulmonary Function

The pulmonary function as assessed by the measurement of tidal volume.

Time frame: end of intervention

Population: t -test

ArmMeasureValue (MEAN)Dispersion
Sham GroupPulmonary Function164.7 mlStandard Deviation 102.7
Electrical StimulationPulmonary Function214.4 mlStandard Deviation 57.3
p-value: 0.051t-test, 2 sided
Secondary

Hospitalization Outcomes

The total days that participants stay in the respiratory care center (RCC).

Time frame: the day participants were discharged from RCC

Population: t test

ArmMeasureValue (MEAN)Dispersion
Sham GroupHospitalization Outcomes34.2 daysStandard Deviation 18.2
Electrical StimulationHospitalization Outcomes32.3 daysStandard Deviation 22.2
p-value: 0.792t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 22, 2026